Vinati Organics Gets 'Buy' Upgrade From PL Capital Post Q1 Result Citing Margin Resilience, Capacity Expansion

7 hours ago 3

ARTICLE AD BOX

Upcoming product launches including anisole, 4MAP, TAA, and PTAP, expected in Q2 FY26 and Q3 FY26 are likely to strengthen the growth trajectory, adds the brokerage.

19 Aug 2025, 12:40 PM IST i

19 Aug 2025, 12:40 PM IST

19 Aug 2025, 12:40 PM IST

<div class="paragraphs"><p>Vinati Organics standalone and consolidated revenue stood at Rs 5.4 billion, the actual topline was 9% lower than PL Capital's estimates.</p><p>(Photo Source: freepik). </p></div>

Vinati Organics standalone and consolidated revenue stood at Rs 5.4 billion, the actual topline was 9% lower than PL Capital's estimates.

(Photo Source: freepik).

ATBS, Vinati Organics’ flagship high-margin product, continued to deliver robust growth and remains oversold, likely to be supported by rising demand from the oil and gas sector where it is used as a tertiary oil recovery agent.

To continue reading this story

You must be an existing Premium User

Already a Premium User?

Read Entire Article